XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net $ 10 $ (3) $ 12 $ (1)
Exit and other-related costs 18 22 40 43
Asset impairments and accelerated depreciation 0 11 28 11
Total 28 30 80 53
Operating Segments | U.S. Pharmaceutical        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 8 0 9 3
Exit and other-related costs 1 0 2 1
Asset impairments and accelerated depreciation 0 3 0 3
Total 9 3 11 7
Operating Segments | Prescription Technology Solutions        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 0 0 0
Exit and other-related costs 3 1 5 3
Asset impairments and accelerated depreciation 0 6 0 11
Total 3 7 5 14
Operating Segments | Medical-Surgical Solutions        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 0 0 0
Exit and other-related costs 4 1 6 2
Asset impairments and accelerated depreciation 0 0 0 0
Total 4 1 6 2
Operating Segments | International        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 2 2 2 2
Exit and other-related costs 4 6 9 8
Asset impairments and accelerated depreciation 0 1 1 1
Total 6 9 12 11
Corporate        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 (5) 1 (6)
Exit and other-related costs 6 14 18 29
Asset impairments and accelerated depreciation 0 1 27 (4)
Total $ 6 $ 10 $ 46 $ 19